FEEDS |

BEE deal the right medicine - Adcock

Nov 24, 2009 10:42 PM | By Adele Shevel

South Africa's second largest pharmaceutical company, Adcock Ingram, is to facilitate an effective acquisition of 13% of its issued share capital by black South African employees and broad-based black economic empowerment groupings.


Current Font Size:
Adcock Ingram CEO, Dr Jonathan Louw, presents the interims. pic MARIANNE SCHWANKHART 02/06/2009. © THE TIMES
Adcock Ingram CEO, Dr Jonathan Louw, presents the interims. pic MARIANNE SCHWANKHART 02/06/2009. © THE TIMES

Valued at R1.3-billion, the Kagiso Health Consortium and Kurisani Youth Development Trust will indirectly hold interests of 7.15% and 2.6% of Adcock's share capital, respectively.

Adcock said these partners were chosen for the their business and broad-based empowerment credentials, and for healthcare and education initiatives they provide to underprivileged communities.

The BEE partners will acquire 75% of the deal. The remaining 25% has been set aside for employees. Chief executive Jonathan Louw said it was a "one-size fits all" deal.

Adcock's future black South African employees will receive the same entitlement.

The company yesterday presented its first full-year results since unbundling from Tiger Brands and listing on the JSE.

Turnover for the year ended September was up 21.3% at R4-billion, benefiting from 12% volume growth, a single exit price increase and an improved product mix.

Profit after tax rose 19.1% to R789.9-million.

 Loading...

 or  to comment

Comments



Be the first to comment

Today's Topics